To describe 2 cases of ipsilateral programmable ventriculoperitoneal shunt placement and cochlear implantation, and provide recommendations on the specific risks and perioperative considerations related to magnetic interactions between devices....
When a patient requires ipsilateral cochlear implantation and has a programmable VP shunt, implement a formal perioperative protocol to monitor and reset shunt valve settings, as magnetic interactions can inadvertently reprogram shunt pressure and cause serious neurological harm.
As cochlear implant candidacy expands to medically complex patients, neurosurgical co-management protocols for device interactions like CI-VP shunt magnetic interference become essential for patient safety.
- 01Two patients underwent ipsilateral CI placement with a programmable ventriculoperitoneal (VP) shunt in place.
- 02Magnetic components of cochlear implants can inadvertently reprogram programmable VP shunt valves.
- 03Unintended shunt reprogramming can cause serious complications including over- or under-drainage of cerebrospinal fluid.
- 04Authors provide perioperative management recommendations for this dual-device scenario.
- 05Case series highlights a gap in multidisciplinary surgical planning for complex CI candidates.
Magnetic interactions between cochlear implants and programmable VP shunts pose a safety risk that can inadvertently reprogram shunt valve settings.
studysupportedPerioperative management protocols can reduce the risk of adverse magnetic interactions in patients with both devices.
studypartially supported- PMID
- 42241273
- DOI
- 10.1097/MAO.0000000000004951.
- Journal
- Otology & Neurotology
- Publication type
- case_report
- Evidence level
- 4
- Sample size
- 2
- Population
- Patients who underwent ipsilateral cochlear implantation with a co-existing programmable ventriculoperitoneal shunt
- Intervention
- Ipsilateral cochlear implantation in patients with programmable ventriculoperitoneal shunts
Primary outcomes
Safety risks from magnetic interactions between cochlear implant and VP shunt; Perioperative management strategies to prevent adverse shunt reprogramming